{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:42:06Z","timestamp":1781066526796,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.physbeh.2021.113541","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T22:50:54Z","timestamp":1627599054000},"page":"113541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effects of pramlintide on energy intake and food preference in rats given a choice diet"],"prefix":"10.1016","volume":"240","author":[{"given":"Katherine A.","family":"Kern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianne M.","family":"DiBrog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan T.","family":"Przybysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Mietlicki-Baase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2021.113541_bib0001","first-page":"1","article-title":"Prevalence of obesity among adults and youth: United States, 2015-2016","author":"Hales","year":"2017","journal-title":"NCHS Data Brief."},{"key":"10.1016\/j.physbeh.2021.113541_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3810\/pgm.2009.11.2074","article-title":"The medical risks of obesity","volume":"121","author":"Pi-Sunyer","year":"2009","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.physbeh.2021.113541_bib0003","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.2018.13022","article-title":"Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.physbeh.2021.113541_bib0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mcna.2017.08.010","article-title":"Obesity Pharmacotherapy","volume":"102","author":"Saunders","year":"2018","journal-title":"Med Clin North Am."},{"key":"10.1016\/j.physbeh.2021.113541_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejim.2015.01.005","article-title":"Drug treatment of obesity: current status and future prospects","volume":"26","author":"Kakkar","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.physbeh.2021.113541_bib0006","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrendo.2010.19","article-title":"Pharmacological management of appetite expression in obesity","volume":"6","author":"Halford","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.physbeh.2021.113541_bib0007","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0031-9384(94)90076-0","article-title":"Reduction of food intake in rats by intraperitoneal injection of low doses of amylin","volume":"55","author":"Lutz","year":"1994","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2021.113541_bib0008","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF01623160","article-title":"Circadian anorectic effects of peripherally administered amylin in rats","volume":"34","author":"Lutz","year":"1995","journal-title":"Z. Ernahrungswiss."},{"key":"10.1016\/j.physbeh.2021.113541_bib0009","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0031-9384(95)02067-5","article-title":"Amylin decreases meal size in rats","volume":"58","author":"Lutz","year":"1995","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2021.113541_bib0010","doi-asserted-by":"crossref","first-page":"E620","DOI":"10.1152\/ajpendo.00217.2007","article-title":"Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study","volume":"293","author":"Smith","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2021.113541_bib0011","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","article-title":"Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells","volume":"39","author":"Kahn","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2021.113541_bib0012","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","article-title":"Control of energy homeostasis by amylin","volume":"69","author":"Lutz","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.physbeh.2021.113541_bib0013","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.physbeh.2004.01.006","article-title":"Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats","volume":"81","author":"Mollet","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2021.113541_bib0014","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.ijo.0801664","article-title":"The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema\/nucleus of the solitary tract (AP\/NTS) lesioned rats","volume":"25","author":"Lutz","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.physbeh.2021.113541_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0196-9781(97)00292-1","article-title":"Lesion of the area postrema\/nucleus of the solitary tract (AP\/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats","volume":"19","author":"Lutz","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2021.113541_bib0016","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/npp.2013.66","article-title":"Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake","volume":"38","author":"Mietlicki-Baase","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2021.113541_bib0017","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0196-9781(98)00114-4","article-title":"Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats","volume":"19","author":"Lutz","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2021.113541_bib0018","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0196-9781(91)90148-I","article-title":"Amylin decreases food intake in mice","volume":"12","author":"Morley","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2021.113541_bib0019","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.clinthera.2007.04.005","article-title":"Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus","volume":"29","author":"Singh-Franco","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.physbeh.2021.113541_bib0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin","volume":"37","author":"Young","year":"1996","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.physbeh.2021.113541_bib0021","first-page":"317","article-title":"Amylin-based pharmacotherapy-past, present & future","volume":"8","author":"Roth","year":"2008","journal-title":"Immunol. Endocr. Metabol. Agent. Med. Chem. (Formerly Current Medicinal Chemistry-Immunology, Endocrine and Metabolic Agents)"},{"key":"10.1016\/j.physbeh.2021.113541_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/en.2013-1658","article-title":"Activity of pramlintide, rat and human amylin but not Abeta1-42 at human amylin receptors","volume":"155","author":"Gingell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2021.113541_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.regpep.2012.08.006","article-title":"[D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK\/6-m db\/db mice","volume":"179","author":"Leinung","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.physbeh.2021.113541_bib0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/dmrr.419","article-title":"Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study","volume":"20","author":"Maggs","year":"2004","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.physbeh.2021.113541_bib0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2002-34790","article-title":"The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus","volume":"34","author":"Fineman","year":"2002","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.physbeh.2021.113541_bib0026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2982.2002.00311.x","article-title":"Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus","volume":"14","author":"Vella","year":"2002","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.physbeh.2021.113541_bib0027","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/diacare.25.4.724","article-title":"A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes","volume":"25","author":"Whitehouse","year":"2002","journal-title":"Diabetes Care."},{"key":"10.1016\/j.physbeh.2021.113541_bib0028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/15209150252924094","article-title":"Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes","volume":"4","author":"Ratner","year":"2002","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.physbeh.2021.113541_bib0029","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/oby.2004.76","article-title":"Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients","volume":"12","author":"Hollander","year":"2004","journal-title":"Obes. Res."},{"key":"10.1016\/j.physbeh.2021.113541_bib0030","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial","volume":"26","author":"Hollander","year":"2003","journal-title":"Diabetes Care."},{"key":"10.1016\/j.physbeh.2021.113541_bib0031","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","article-title":"Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes","volume":"48","author":"Chapman","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2021.113541_bib0032","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/oby.2007.626","article-title":"Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects","volume":"15","author":"Chapman","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.physbeh.2021.113541_bib0033","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1210\/jc.2006-2003","article-title":"Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study","volume":"92","author":"Aronne","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2021.113541_bib0034","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/dc08-0029","article-title":"Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity","volume":"31","author":"Smith","year":"2008","journal-title":"Diabetes Care."},{"key":"10.1016\/j.physbeh.2021.113541_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tips.2013.11.003","article-title":"Feelings about food: the ventral tegmental area in food reward and emotional eating","volume":"35","author":"Meye","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2021.113541_bib0036","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1467-789X.2007.00321.x","article-title":"Understanding the mechanisms of food intake and obesity","volume":"8","author":"Rolls","year":"2007","journal-title":"Obes. Rev."},{"key":"10.1016\/j.physbeh.2021.113541_bib0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.trci.2016.11.005","article-title":"Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease","volume":"3","author":"Soudy","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.physbeh.2021.113541_bib0038","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.physbeh.2014.01.013","article-title":"Amylin activates distributed CNS nuclei to control energy balance","volume":"136","author":"Mietlicki-Baase","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2021.113541_bib0039","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1210\/en.2005-0774","article-title":"Divergent behavioral roles of angiotensin receptor intracellular signaling cascades","volume":"146","author":"Daniels","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2021.113541_bib0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2017.05.024","article-title":"Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior","volume":"123","author":"Mietlicki-Baase","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2021.113541_bib0041","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.physbeh.2008.08.004","article-title":"The effect of ghrelin on water intake during dipsogenic conditions","volume":"96","author":"Mietlicki","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2021.113541_bib0042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2007.06.016","article-title":"Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK","volume":"1162","author":"Becskei","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2021.113541_bib0043","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.physbeh.2017.03.023","article-title":"The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc)","volume":"176","author":"Whiting","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2021.113541_bib0044","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2021.113541_bib0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0031-9384(98)00110-3","article-title":"Synergy between amylin and cholecystokinin for inhibition of food intake in mice","volume":"64","author":"Bhavsar","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2021.113541_bib0046","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0196-9781(91)90038-Q","article-title":"Syntheses, structures and anorectic effects of human and rat amylin","volume":"12","author":"Balasubramaniam","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2021.113541_bib0047","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(93)91505-M","article-title":"Anorexia following the systemic injection of amylin","volume":"607","author":"Chance","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2021.113541_bib0048","first-page":"R1654","article-title":"Chronic infusion of islet amyloid polypeptide causes anorexia in rats","volume":"271","author":"Arnelo","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.physbeh.2021.113541_bib0049","first-page":"E943","article-title":"Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats","volume":"264","author":"Young","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.physbeh.2021.113541_bib0050","doi-asserted-by":"crossref","first-page":"R1855","DOI":"10.1152\/ajpregu.00297.2007","article-title":"Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight","volume":"293","author":"Mack","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2021.113541_bib0051","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1210\/en.2012-2172","article-title":"Amylin acts in the central nervous system to increase sympathetic nerve activity","volume":"154","author":"Fernandes-Santos","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2021.113541_bib0052","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2003.10.040","article-title":"Peripheral amylin activates circumventricular organs expressing calcitonin receptor a\/b subtypes and receptor-activity modifying proteins in the rat","volume":"997","author":"Barth","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2021.113541_bib0053","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/ejn.13163","article-title":"Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons","volume":"43","author":"Liberini","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2021.113541_bib0054","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0169-328X(01)00179-6","article-title":"Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain","volume":"93","author":"Ueda","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.physbeh.2021.113541_bib0055","doi-asserted-by":"crossref","first-page":"R788","DOI":"10.1152\/ajpregu.00539.2015","article-title":"Mapping the calcitonin receptor in human brain stem","volume":"310","author":"Bower","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2021.113541_bib0056","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2004.10.012","article-title":"Immunohistochemical mapping of calcitonin receptors in the adult rat brain","volume":"1030","author":"Becskei","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2021.113541_bib0057","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.0953-816x.2001.01688.x","article-title":"Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat","volume":"14","author":"Oliver","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2021.113541_bib0058","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1113\/EP088356","article-title":"Palatable food access impacts expression of amylin receptor components in the mesocorticolimbic system","volume":"105","author":"Nashawi","year":"2020","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.physbeh.2021.113541_bib0059","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2021.113541_bib0060","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/0024-3205(95)02197-Q","article-title":"Permeability of the blood-brain barrier to amylin","volume":"57","author":"Banks","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.physbeh.2021.113541_bib0061","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cmet.2015.10.012","article-title":"Hypothalamic amylin acts in concert with leptin to regulate food intake","volume":"22","author":"Li","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2021.113541_bib0062","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1471-4159.2009.06422.x","article-title":"Central amylin expression and its induction in rat dams","volume":"111","author":"Dobolyi","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2021.113541_bib0063","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1096\/fj.11-191841","article-title":"Amylin is a novel neuropeptide with potential maternal functions in the rat","volume":"26","author":"Szabo","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.physbeh.2021.113541_bib0064","doi-asserted-by":"crossref","first-page":"R1215","DOI":"10.1152\/ajpregu.00446.2012","article-title":"Sex differences in the physiology of eating","volume":"305","author":"Asarian","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938421002316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938421002316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:18:58Z","timestamp":1758478738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938421002316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":64,"alternative-id":["S0031938421002316"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2021.113541","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of pramlintide on energy intake and food preference in rats given a choice diet","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2021.113541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113541"}}